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Abstract: A better understanding of what drives behaviour change in obese pregnant overweight
women is needed to improve the effectiveness of lifestyle interventions in this group at risk for
gestational diabetes (GDM). Therefore, we assessed which factors mediated behaviour change in
the Vitamin D and Lifestyle Intervention for GDM Prevention (DALI) Lifestyle Study. A total of
436 women, with pre-pregnancy body mass index ≥29 kg/m2, ≤19 + 6 weeks of gestation and
without GDM, were randomised for counselling based on motivational interviewing (MI) on healthy
eating and physical activity, healthy eating alone, physical activity alone, or to a usual care group.
Lifestyle was measured at baseline, and at 24–28 and 35–37 weeks of gestation. Outcome expectancy,
risk perception, task self-efficacy and social support were measured at those same time points and
considered as possible mediators of intervention effects on lifestyle. All three interventions resulted in
increased positive outcome expectancy for GDM reduction, perceived risk to the baby and increased
task self-efficacy. The latter mediated intervention effects on physical activity and reduced sugared
drink consumption. In conclusion, our MI intervention was successful in increasing task self-efficacy,
which was related to improved health behaviours.
Keywords: lifestyle intervention; behaviour change; mediation; pregnancy; obesity;
gestational diabetes
1. Introduction
The prevalence of maternal obesity in pregnancy has increased in the past decades [1,2] and is
associated with increased risks for both mother and offspring. In particular, women with obesity and
women with excess gestational weight gain have an increased risk for developing gestational diabetes
(GDM) [3,4]. To date, lifestyle interventions aimed to reduce the risk of GDM in women with obesity
have shown only limited success [5], but do have the potential to improve lifestyle behaviours [6–8]
and to modestly limit gestational weight gain [5].
The Vitamin D and Lifestyle Intervention for GDM Prevention (DALI) Lifestyle Study was
designed to offer lifestyle counselling to obese pregnant women, in order to prevent GDM. In the
DALI Lifestyle Study, the women were counselled based on seven healthy eating messages
and/or five physical activity messages [9]. The counsellors used principles of motivational
interviewing [10] to enhance intrinsic motivation and action planning for healthy eating and/or
physical activity. We previously reported positive changes in some lifestyle behaviours and
a relevant reduction in gestational weight gain in a combined healthy eating and physical
activity intervention [11]. Although no improvements in glucose metabolism were observed [11],
the combined healthy eating and physical activity intervention was cost-effective [12], and effective
in reducing neonatal adiposity [13]. Combined, these effects warrant further implementation of
the DALI combined intervention, or a similar intervention, for obese pregnant women. Therefore,
understanding mechanisms behind behaviour change is important for improving future interventions.
The DALI protocol and measures were informed by the Health Action Process Approach
(HAPA) [14], a theory of behaviour change, widely applied in lifestyle interventions, including those
aimed at prevention of type 2 diabetes [15]. Recently, it was also found to be useful in explaining
physical activity levels of women with a recent history of GDM [16]. HAPA provides a framework
for understanding the process of adoption, initiation and maintenance of health behaviours. In the
motivation phase preceding the volition phase (where actual behaviour change is realised), high-risk
perception, positive outcome expectancies and perceived self-efficacy are regarded as three key
determinants. Once intention to change is formed, self-efficacy and perceived social support remain
important mediators in the process of action planning and maintenance of behaviour change [14,17].
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Here, we report on secondary analyses, with the aim to enhance our understanding about why
obese pregnant women change, or do not change, their behaviour. This should help us further improve
lifestyle interventions for this particular patient group at high risk of GDM. As determinants of
behaviour change might differ between separate lifestyle behaviours, we aimed to assess which factors
mediated behaviour change for each lifestyle factor, separately, in the DALI Lifestyle Study.
2. Materials and Methods
2.1. Design and Participants
The DALI Lifestyle Study was a multi-centre randomised trial conducted in nine European
countries (Austria, Belgium, Denmark (Odense, Copenhagen), Ireland, Italy (Padua, Pisa), Netherlands,
Poland, Spain and United Kingdom) during 2012–2015. Local ethics committee approval and written
informed consent for all women was obtained. Pregnant women with a pre-pregnancy body mass
index (BMI) of≥29 kg/m2,≤19 + 6 weeks of gestation, a singleton pregnancy and aged≥18 years were
invited to participate. Exclusions included diagnosis with early gestational diabetes [18], pre-existing
diabetes and chronic medical conditions [9]. Measurements occurred at baseline (prior to 20 weeks of
gestation), and at 24–28 and 35–37 weeks of gestation.
2.2. Randomisation and Interventions
Women were randomised to a healthy eating and physical activity (HE&PA), healthy eating alone
(HE), physical activity alone (PA) group or a usual care (UC) group, using a computerised random
number generator, pre-stratified for site. Staff involved with measurements, but not participants,
were blinded to the intervention.
In the intervention groups, participants were assigned to a single coach, with whom they
discussed five physical activity and/or seven healthy eating messages (See Table S1), depending on
group allocation, and were advised to keep gestational weight gain below 5 kg. The 5 kg weight
gain target—without gestational weight loss—rather than the 9 kg recommended by the Institute of
Medicine [19] was chosen since it was associated with less adverse outcomes in previous studies [20,21].
Coaching, guided by principles of motivational interviewing, took place during five face-to-face
sessions of 30–45 min each, alternated with up to four optional telephone calls. In the UC group,
participants received no DALI interventions.
2.3. Outcomes
Levels of physical activity were assessed using the Pregnancy Physical Activity Questionnaire
(PPAQ) [22] at the three time points. The original PPAQ consisted of 32 activities including
household/caregiving, occupational, sports/exercise and inactivity measured during the current
trimester. Open-ended questions allowed the respondent to add activities not already listed. In DALI,
two questions for cycling to work (4.0 MET (metabolic equivalent of task)) and recreational cycling
(8.0 MET) were added, due to the frequent performance of these activities in some European countries.
Participants were asked to select the category that best approximated the amount of time spent in
one of these activities. The duration of time spent in each activity was multiplied by its intensity
such that an average weekly energy expenditure (MET hours/week) was calculated for each activity.
For the open-ended reported activities, a compendium of physical activities was used to obtain MET
values for intensity [23]. Activities were categorised by intensity (sedentary, light, moderate, vigorous),
type and total activity (sum of all activity with an intensity above 1.5 MET). Self-reported moderate
and vigorous activity were summed and presented as MET hours/week of moderate-to-vigorous
physical activity.
Nutrition was assessed using a bespoke short food frequency questionnaire covering key foods
linked to the intervention messages and based upon prior work [24]. The number of portions/week for
each key food component (sugared drink, vegetable, carbohydrate, protein, fibre, and fat consumption)
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was calculated as the product of the frequency consumed/week and the number of portions per
episode. A portion was the amount of food that can fit into the palm of your hand or 200 mL of
fluid (a medium sized cup or glass). Portion size was calculated as the number of portions of food
components per week.
The outcomes reported in this paper were limited to the six lifestyle factors that changed
significantly from baseline to 24–28 weeks or 35–37 weeks of gestation due to the either the HE&PA,
HE or PA intervention (moderate-to-vigorous physical activity, sedentary behaviour, sugared drink
consumption, vegetable consumption, carbohydrate intake and portion size).
2.4. Potential Mediators
Based on the HAPA model [14], perceived risk, outcome expectancy, social support and self- efficacy
relating to weight control, physical activity and nutrition were assessed at all three time points.
Perceived risk for developing GDM was assessed with the following question: “What do you think
is your risk of developing GDM?” Answering options ranged from 1 (very low) to 5 (very high).
Outcome expectancy, social support and self-efficacy were asked with multiple single statements, as have
been used in multiple previous studies, with possible answering options ranging from 1 (fully disagree)
to 10 (fully agree). For example, “I believe that increasing my physical activity level will reduce my risk
for developing GDM” (fully disagree–fully agree). The full list of items can be found in Table S1.
For outcome expectancy for GDM risk reduction and for outcome expectancy for a reduction of
risk to the baby, the scores of two items concerning managing weight and staying active were combined.
For instance, for outcome expectancy for GDM risk reduction, the score for the item “Managing my
weight during this pregnancy, will help me to reduce my risk of developing GDM” and the score for the item
“Staying physically active during this pregnancy, will help me to reduce my risk of developing GDM” were
summed and divided by 2 (see also Table S1). The combined variable was then tested as potential
mediator for intervention effects on sedentary behaviour and moderate-to-vigorous physical activity.
Similarly, the scores for the items concerning weight management and healthy eating were averaged,
and the combined variable tested as mediator of intervention effects on nutrition outcomes. For task
self-efficacy, the three items for the confidence in being able to control weight, to be physically active in
the short and in the long term were averaged, as well as the three items for weight control and healthy
nutrition in the short and the long term.
2.5. Statistical Analyses
Differences between intervention groups were tested using ANOVA for continuous variables,
or chi-square or Fisher’s exact tests for categorical variables. When significant differences were
detected with ANOVA, the intervention groups were compared to UC group with Tukey’s post-hoc
tests. All analyses were performed in SPSS version 22 (IBM Corp, Armonk, NY, USA). A two-sided
p < 0.05 was considered significant for differences between groups. No adjustments for multiple
comparisons were made.
Mediation of intervention effects at 24–28 weeks and at 35–37 weeks by different psychological
constructs at 24–28 and 35–37 weeks was assessed in parallel mediation analyses [25,26].
Multiple mediation models are preferred over simple mediation models as most effects operate
through multiple mechanisms at once. Furthermore, this allows the determinations of the strongest
indirect effect [25].
The PROCESS macro (version 2.16) was run to compute the following steps simultaneously:
(1) estimation of the intervention effects on the mediators by regressing the mediator score on the
baseline mediator score, confounders and intervention dummies (a-coefficient); (2) estimation of
whether changes in the mediators predict changes in the outcome variables by regressing the outcome
variables onto the baseline values of the mediators, mediators, baseline values of the lifestyle outcome
and intervention dummies (b-coefficient); (3) estimation of the indirect effect (a × b-coefficient);
(4) estimation of the direct effect when accounted for the indirect effect (c’-path); (5) estimation of
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the total intervention effect (c-path). The results of these intervention effects on lifestyle outcomes
vary somewhat from those previously published [11], due to differences in sample size and analysis
method. For all mediation analyses, clustering per site was taken into account.
Bias-corrected bootstrapped 95% asymmetric confidence intervals (based on 10,000 bootstrap
samples) were computed for the indirect effect [25]. The indirect effect is statistically different from zero
if the confidence interval does not straddle zero. PROCESS was run for each lifestyle outcome with the
same value for the random number seed attributed to each run. This was done to obtain results as if all
the paths were estimated in one model with multiple dependent variables. The intervention condition
is a multi-categorical independent variable and was therefore analysed with dummy coding [26].
3. Results
Maternal baseline characteristics were comparable between groups (Table 1). Psychological variables
and lifestyle behaviours per intervention group are described in Table 2 for all three time points in
pregnancy. No baseline differences in psychological variables were found. Women’s expectancy—that
managing weight, increasing physical activity and healthy eating would lead to a reduction in GDM risk
and in a risk reduction for their baby—was high at the start of the study. Task self-efficacy for healthy
eating was somewhat higher than for physical activity.
3.1. Intervention Effects on Psychological Variables (A-Path)
Intervention effects on psychological variables at 24–28 and 35–37 weeks can be found in Table 3
and Figures 1–3 (a-path). Small variations in results are due to differences in sample sizes in the
various analyses. In general, all three interventions increased the women’s expectancy that managing
weight, increasing physical activity and healthy eating would lead to a reduction in GDM risk and
in a risk reduction for their baby. Furthermore, both the HE&PA and PA intervention increased task
self-efficacy for physical activity. Task self-efficacy for healthy eating was increased in the HE&PA
and HE group. In the HE&PA intervention, increased satisfaction with social support was observed
for physical activity. Satisfaction with social support for healthy eating increased in the HE group,
but was only statistically significant in some of the analyses, depending on the outcome variable tested
in the mediation model and the number of participants having missing data for this specific outcome
variable. None of the interventions had an effect on the perceived risk of developing GDM.
3.2. Association of Psychological Variables with Lifestyle Behaviours (B-Path)
Task self-efficacy for physical activity at 24–28 weeks was positively associated with
moderate-to-vigorous physical activity (MVPA) at 24–28 (0.04; 95% confidence interval [CI] 0.02,
0.07) and 35–37 weeks (0.03; 95% CI 0.02, 0.06) (Figure 1A,B; Table S2a). Outcome expectancy of a
reduction in GDM risk at 35–37 weeks was positively associated with MVPA at the same time point
(0.04; 95% CI 0.001, 0.07, p = 0.047). Task self-efficacy for healthy eating at 24–28 and 35–37 weeks
was negatively associated with sugared drink consumption at the same time point (for 24–28 weeks
−0.24; 95% CI −0.42, −0.06; for 35–37 weeks −0.25; 95% CI −0.41, −0.09). The association of task
self-efficacy at 24–28 weeks with sugared drink consumption at 35–37 weeks was not significant
(−0.24; 95% CI −0.51, 0.04) (Table S2c). Increased satisfaction with social support for healthy eating at
24–28 weeks was negatively associated with portion size at 35–37 weeks (−1.15; 95% CI −2.30, −0.01)
(Table S2f). Outcome expectancy of reduced risk for their baby at 35–37 weeks (0.79; 95% CI 0.09,
1.48) and task self-efficacy at 35–37 weeks (−0.55; 95% CI −0.95, −0.15) were associated with portion
size at 35–37 weeks. No other significant associations between psychological variables and lifestyle
behaviours were observed (Table S2a–f).
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Table 1. Baseline characteristics of all women included per intervention group.
Variable UC
n = 105
HE&PA
n = 108
HE
n = 113
PA
n = 110
Total
n = 436
p
Age, year, mean ± SD 31.8 ± 5.6 31.9 ± 5.3 32.5 ± 5.5 31.7 ± 5.1 32.0 ± 5.4 0.68
Multiparous, n (%) 50 (48%) 56 (52%) 64 (57%) 51 (46%) 221 (51%) 0.41
European descent, n (%) 94 (90%) 95 (88%) 95 (84%) 94 (86%) 378 (87%) 0.65
Lives with partner, n (%) 100 (95%) 99 (92%) 108 (96%) 103 (94%) 410 (94%) 0.60
Higher education, n (%) 55 (52%) 59 (55%) 65 (58%) 60 (55%) 239 (55%) 0.90
Maternal smoking, n (%) 18 (17%) 11 (10%) 20 (18%) 18 (17%) 67 (15%) 0.38
History of GDM, n (%) 3 (5%) 4 (6%) 6 (7%) 4 (6%) 17 (6%) 0.95
1st degree FH DM, n (%) 28 (27%) 18 (17%) 28 (25%) 27 (25%) 101 (23%) 0.31
Chronic hypertension, n (%) 9 (9%) 12 (11%) 17 (15%) 17 (16%) 55 (13%) 0.36
Gestation on entry, weeks, mean ± SD 15.2 ± 2.4 15.2 ± 2.2 15.3 ± 2.5 15.5 ± 2.3 15.3 ± 2.3 0.58
Weight at entry, kg, mean ± SD 94.2 ± 12.6 95.2 ± 13.8 94.9 ± 13.2 94.6 ± 12.8 94.7 ± 13.1 0.89
Height, cm, mean ± SD 165.9 ± 6.7 166.0 ± 6.6 165.2 ± 6.6 165.6 ± 7.2 165.7 ± 6.8 0.81
BMI at entry, kg/m2, mean ± SD 34.2 ± 3.9 34.5 ± 4.0 34.7 ± 4.2 34.4 ± 3.8 34.5 ± 4.0 0.83
Abbreviations: UC = usual care; HE = healthy eating; PA = physical activity; HE&PA = healthy eating and physical activity; GDM = gestational diabetes; FH DM = family history
of diabetes; SD = standard deviation; BMI = body mass index. p values of the tests for differences between groups are based on chi-square test (dichotomous variables) or ANOVA
(continuous variables).
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Table 2. Potential mediators and lifestyle outcomes per intervention group at all three time points.
Psychological Variables UC HE&PA HE PA
Baseline <20 Weeks n Mean ± SD n Mean ± SD n Mean ± SD n Mean ± SD p
Attitude towards weight (range 2–20) 103 15.7 ± 3.4 108 15.2 ± 4.1 112 15.3 ± 3.5 107 15.9 ± 3.6 0.41
Perceived risk for GDM (range 1–5) 105 2.8 ± 0.8 107 2.8 ± 0.9 113 2.9 ± 0.8 110 2.9 ± 0.9 0.75
Outcome expectancy GDM risk reduction (range 2–20)
Healthy eating 104 16.5 ± 3.1 106 16.6 ± 3.0 112 16.8 ± 2.9 108 17.0 ± 3.0 0.60
Physical activity 103 16.3 ± 3.0 106 16.3 ± 3.2 112 16.5 ± 3.0 106 16.8 ± 3.2 0.64
Outcome expectancy risk reduction baby (range 2–20)
Healthy eating 104 17.3 ± 2.5 106 16.8 ± 3.0 112 17.5 ± 2.7 109 17.7 ± 2.6 0.11
Physical activity 104 16.8 ± 2.7 107 16.6 ± 3.2 112 17.3 ± 2.8 110 17.4 ± 2.8 0.09
Task self-efficacy (range 3–30)
Healthy eating 104 21.2 ± 5.2 108 22.0 ± 5.1 112 21.3 ± 5.2 110 21.8 ± 5.0 0.63
Physical activity 104 20.7 ± 5.2 107 20.8 ± 5.1 112 20.7 ± 5.1 109 21.4 ± 5.5 0.67
Satisfaction with social support (range 1–10)
Healthy eating 104 7.6 ± 2.0 108 7.6 ± 1.9 112 7.4 ± 2.1 109 7.8 ± 2.2 0.61
Physical activity 104 7.7 ± 2.0 108 7.5 ± 2.1 112 7.4 ± 2.3 108 7.8 ± 2.2 0.39
24–28 weeks
Attitude towards weight (range 2–20) 99 13.9 ± 3.7 95 14.8 ± 3.5 104 14.7 ± 3.8 101 14.7 ± 3.5 0.30
Perceived risk for GDM (range 1–5) 100 2.6 ± 0.9 95 2.7 ± 1.0 104 2.7 ± 0.9 100 2.6 ± 1.0 0.87
Outcome expectancy GDM risk reduction (range 2–20)
Healthy eating 100 15.5 ± 3.3 95 16.5 ± 3.6 105 16.9 ± 3.1 101 16.6 ± 3.2 0.01
Physical activity 100 15.1 ± 3.5 94 16.3 ± 3.7 105 16.5 ± 3.3 101 16.6 ± 3.3 0.005
Outcome expectancy risk reduction baby (range 2–20)
Healthy eating 101 16.2 ± 3.3 94 17.0 ± 3.4 104 17.5 ± 3.0 101 17.5 ± 2.5 0.01
Physical activity 101 16.0 ± 3.5 95 16.8 ± 3.5 104 17.2 ± 3.0 101 17.4 ± 2.6 0.01
Task self-efficacy (range 3–30)
Healthy eating 101 19.4 ± 4.7 96 21.8 ± 4.5 104 21.5 ± 4.7 100 20.5 ± 5.3 0.002
Physical activity 100 18.6 ± 5.0 96 20.6 ± 5.0 105 19.6 ± 5.3 101 20.9 ± 5.6 0.01
Satisfaction with social support (range 1–10)
Healthy eating 101 7.5 ± 1.8 96 7.8 ± 2.0 105 7.8 ± 2.0 101 7.8 ± 2.0 0.58
Physical activity 100 7.2 ± 2.1 96 7.8 ± 2.0 105 7.6 ± 2.3 101 8.0 ± 2.2 0.047
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Table 2. Cont.
35–37 weeks
Attitude towards weight (range 2–20) 89 13.0 ± 4.3 86 14.1 ± 4.0 88 14.0 ± 4.1 89 14.4 ±3.9 0.14
Perceived risk for GDM (range 1–5) 86 2.3 ± 1.1 86 2.1 ± 1.2 85 2.3 ± 1.1 87 2.1 ± 1.2 0.52
Outcome expectancy GDM risk reduction (range 2–20)
Healthy eating 88 14.2 ± 4.6 85 15.5 ± 5.3 88 15.3 ± 5.0 88 15.7 ± 4.5 0.20
Physical activity 88 13.9 ± 4.7 85 15.3 ± 5.3 87 14.9 ± 5.1 88 15.8 ± 4.6 0.09
Outcome expectancy risk reduction baby (range 2–20)
Healthy eating 89 15.5 ± 3.6 85 16.8 ± 3.5 87 16.7 ± 3.0 89 16.7 ± 3.0 0.03
Physical activity 89 15.2 ± 3.9 85 16.5 ± 3.6 87 16.4 ± 3.1 89 16.7 ± 3.1 0.02
Task self-efficacy (range 3–30)
Healthy eating 88 19.9 ± 4.9 83 22.1 ± 5.5 88 21.5 ± 4.4 89 20.8 ± 5.8 0.03
Physical activity 88 17.4 ± 5.7 84 19.4 ± 5.7 87 19.4 ± 5.7 87 19.7 ± 6.0 0.03
Satisfaction with social support (range 1–10)
Healthy eating 89 7.4 ± 2.1 86 7.7 ± 2.1 88 8.0 ± 1.7 89 7.7 ± 2.1 0.26
Physical activity 89 7.4 ± 2.2 86 7.7 ± 2.2 86 7.9 ± 1.9 89 8.2 ± 1.9 0.10
Lifestyle behaviours
24–28 weeks
MVPA, MET-h/week * 101 29.7 (15.3; 70.3) 96 43.1 (21.0; 77.8) 104 35.7 (17.1; 83.5) 101 51.2 (25.3; 83.5) 0,03
Sedentary behaviour, MET-h/week 101 13.4 ± 9.7 96 10.8 ± 8.9 104 11.8 ± 7.8 101 12.3 ± 7.3 0.19
Sugary drinks, portions/week 96 4.8 ± 5.0 90 5.3 ± 7.6 99 3.2 ± 4.2 96 7.4 ± 9.6 <0.001
Vegetables, portions/week 97 11.6 ± 9.2 91 13.8 ± 8.5 98 15.2 ± 9.7 95 12.7 ± 9.2 0.04
Carbohydrates, portions /week 92 35.8 ± 19.0 87 37.0 ± 17.5 98 32.6 ± 15.6 90 35.4 ± 19.6 0.40
Portion size, portions/week 97 18.1 ± 13.1 91 19.9 ± 17.7 97 14.1 ±10.1 94 20.1 ± 14.4 0.01
35–37 weeks
MVPA, MET-h/week * 89 21.6 (11.6; 42.0) 86 27.2 (7.8; 54.2) 88 21.1 (9.9; 59.6) 88 35.4 (15.8; 60.4) 0.18
Sedentary behaviour, MET-h/week 89 13.8 ± 9.9 86 10.7 ± 7.7 88 13.2 ± 9.6 88 13.9 ± 8.2 0.06
Sugary drinks, portions/week 77 5.4 ± 5.9 79 3.6 ± 4.7 82 3.3 ± 5.1 76 6.2 ± 6.7 0.002
Vegetables, portions/week 86 12.9 ± 9.5 81 12.6 ± 9.2 82 14.2 ± 10.1 82 12.6 ± 11.0 0.69
Carbohydrates, portions/week 77 37.3 ± 19.7 79 32.9 ± 18.4 80 29.6 ± 13.9 77 36.5 ± 20.4 0.03
Portion size, portions /week 81 17.9 ± 13.8 80 16.7 ± 14.1 81 14.8 ± 11.3 80 21.3 ± 17.4 0.03
* Data presented as median (interquartile range) because of skewed distribution. Abbreviations: UC = usual care; HE = healthy eating; PA = physical activity; HE&PA = healthy eating &
physical activity; GDM = gestational diabetes; SD = standard deviation; MVPA = moderate-to-vigorous physical activity; MET = metabolic equivalent of task. p values of the tests for
differences between groups are based on ANOVA (with natural log values for MVPA). Significant differences between intervention group and UC group based on Tukey’s post hoc tests
are in bold.
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Table 3. Intervention effects on psychological variables at 24–28 and 35–37 weeks (a path).*
24–28 Weeks HE&PA vs. UCEstimate (95% CI) p
HE vs. UC
Estimate (95% CI) p
PA vs. UC
Estimate (95% CI) p
Perceived risk for GDM (range 1–5) 0.04 (−0.19; 0.27) 0.74 0.002 (−0.22; 0.23) 0.99 −0.01 (−0.24; 0.22) 0.92
Outcome expectancy GDM risk reduction with physical activity (range 2–20) 1.31 (0.47; 2.14) 0.002 1.24 (0.43; 2.05) 0.003 1.38 (0.56; 2.21) 0.001
Outcome expectancy GDM risk reduction with healthy eating (range 2–20) 1.25 (0.43; 2.07) 0.003 1.24 (0.43; 2.03) 0.003 1.12 (0.30; 1.93) 0.007
Outcome expectancy risk reduction baby with physical activity (range 2–20) 0.83 (0.03; 1.63) 0.04 0.92 (0.14; 1.70) 0.02 0.96 (0.17; 1.75) 0.02
Outcome expectancy risk reduction baby with healthy eating (range 2–20) 0.89 (0.13; 1.66) 0.02 0.91 (0.16; 1.66) 0.02 0.95 (0.19; 1.72) 0.01
Task self-efficacy for physical activity (range 3–30) 2.11 (0.81; 3.42) 0.002 1.09 (−0.18; 2.37) 0.09 1.89 (0.59; 3.18) 0.004
Task self-efficacy for healthy eating (range 3–30) 2.19 (0.94; 3.43) 0.001 2.32 (1.10; 3.54) 0.0002 0.49 (−0.75; 1.73) 0.44
Satisfaction with social support for physical activity (range 1–10) 0.57 (0.06; 1.08) 0.03 0.41 (−0.09; 0.90) 0.11 0.49 (−0.01; 1.00) 0.054
Satisfaction with social support for healthy eating (range 1–10) 0.10 (−0.38; 0.59) 0.67 0.38 (−0.09; 0.84) ** 0.12 0.07 (−0.41; 0.54) 0.78
35–37 weeks HE&PA vs. UCEstimate (95% CI) p
HE vs. UC
Estimate (95% CI) p
PA vs. UC
Estimate (95% CI) p
Perceived risk for GDM (range 1–5) −0.02 (−0.35; 0.31) 0.74 −0.001 (−0.33; 0.32) 0.99 −0.15 (−0.47; 0.18) 0.37
Outcome expectancy GDM risk reduction with physical activity (range 2–20) 1.99 (0.62; 3.36) 0.002 0.87 (−0.49; 2.22) 0.21 1.74 (0.39; 3.10) 0.01
Outcome expectancy GDM risk reduction with healthy eating (range 2–20) 2.09 (0.69; 3.49) 0.004 0.97 (−0.41; 2.35) 0.17 1.32 (−0.05; 2.69) 0.06
Outcome expectancy risk reduction baby with physical activity (range 2–20) 1.29 (0.39; 2.18) 0.04 0.85 (−0.03; 1.74) 0.06 1.25 (0.36; 2.13) 0.01
Outcome expectancy risk reduction baby with healthy eating (range 2–20) 1.46 (0.56; 2.36) 0.002 0.82 (−0.07; 1.71) 0.07 0.82 (−0.06; 1.71) 0.07
Task self-efficacy for physical activity (range 3–30) 2.02 (0.38; 3.67) 0.002 1.98 (0.35; 3.60) 0.02 1.90 (0.27; 3.53) 0.02
Task self-efficacy for healthy eating (range 3–30) 2.01 (0.49; 3.53) 0.01 1.43 (−0.07; 2.93) 0.06 0.37 (−1.12; 1.86) 0.63
Satisfaction with social support for physical activity (range 1–10) 0.63 (0.07; 1.19) 0.03 0.63 (0.08; 1.18) 0.03 0.78 (0.23; 1.33) 0.01
Satisfaction with social support for healthy eating (range 1–10) 0.54 (−0.02; 1.10) 0.06 0.65 (0.10; 1.21) 0.02 0.36 (−0.19; 0.91) 0.20
* Values vary slightly between analyses for different lifestyle outcomes, due to varying sample sizes. ** Satisfaction with social support for HE was statistically significant in the HE group,
depending on the sample. Abbreviations: UC = usual care; HE = healthy eating; PA = physical activity; HE&PA = healthy eating and physical activity; GDM = gestational diabetes.
p values based on regressions from the mediation analyses. Significant differences compared to the UC group are in bold.
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Figure 1. Schematic diagram of the results of mediation by task self-efficacy on moderate-to-vigorous
physical activity. Shown are the path coefficients between intervention condition, task self-efficacy
at 24–28 weeks, and moderate to vigorous physical activity (MVPA) at 24–28 weeks (A) and at
35–37 weeks (B). Statistically significant path coefficients are shown in bold and with solid lines.
Dashed lines indicated non-significant paths. Indirect effects were calculated as the product of the
coefficients of the a and b paths (a × b).
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Figure 3. Schematic diagram of the results of mediation by outcome expectancy or satisfaction with
social support on portion size. Shown are the path coefficients between intervention condition,
outcome expectancy of risk reduction of the baby at 24–28 weeks, and portion size at 24–28 weeks
(A) and between intervention condition, satisfaction with social support, and portion size at
35–37 weeks (B). Statistically significant path coefficients are shown in bold and with solid lines.
Dashed lines indicate non-significant paths. Indirect effects were calculated as the product of the
coefficients of the a and b paths (a × b).
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3.3. Mediation by Psychological Variables of Intervention Effects on Physical Activity and Sedentary Behaviour
(a × b path)
Table S3 shows the total intervention effects on moderate-to-vigorous physical activity (MVPA)
and sedentary behaviour (c-path) at 24–28 and at 35–37 weeks. Task self-efficacy for physical activity
at 24–28 weeks was a mediator of intervention effects on MVPA at 24–28 weeks in both the HE&PA
(indirect effect 0.09 (95% CI 0.03; 0.19)) and the PA group (indirect effect 0.08 (95% CI 0.02; 0.18)). Also,
at 35–37 weeks, task self-efficacy at 24–28 weeks mediated intervention effects on MVPA in those two
groups (HE&PA: indirect effect 0.06 (95% CI 0.01; 0.16); PA: indirect effect 0.08 (95% CI 0.01; 0.20))
(Figure 1A,B, Table S2a). Outcome expectancy of reduction of GDM risk at 35–37 weeks mediated
intervention effects on MVPA at 35–37 weeks in the PA group (indirect effect 0.07 (95% CI 0.001; 0.22).
None of the psychosocial variables at 24–28 or 35–37 weeks mediated intervention effects on sedentary
behaviour at 24–28 or at 35–37 weeks (Table S2b).
3.4. Mediation by Psychological Variables of Intervention Effects on Healthy Eating Behaviours (a × b path)
Table S3 shows the total intervention effects on sugared drink consumption, vegetable consumption
or carbohydrate intake, and portion size (c-path) at 24–28 and at 35–37 weeks. For sugared drink
consumption at 24–28 weeks, two mediating variables were found with opposite effects in the HE&PA
and HE intervention groups (Figure 2, Table S2c). The expectancy that weight management and healthy
eating would result in a risk reduction for the baby was increased in all three intervention groups.
This outcome expectancy was however associated with increased sugared drink consumption, resulting in
significant indirect effects in all three groups (indirect effects HE&PA: 0.38 (95% CI 0.02, 1.13), HE: 0.38
(95% CI 0.01, 1.21), PA: 0.43 (95% CI 0.02, 1.32)). At the same time, task self-efficacy for healthy eating
increased in the HE&PA and HE groups. Higher task self-efficacy was associated with reduced sugared
drink consumption, resulting in significant indirect effects in the HE&PA (−0.56 (95% CI −1.43, −0.07))
and HE group (−0.48 (95% CI −1.27, −0.06)) (Figure 2, Table S2c). Higher task self-efficacy at 35–37
weeks also mediated intervention effects on sugared drink consumption at 35–37 weeks in the HE&PA
group (indirect effect −0.46 (95% CI −1.19; −0.05)).
Outcome expectancy of a risk reduction for the baby at 24–28 was a mediating variable for the
intervention effect on portion size at 24–28 weeks in all three intervention groups (Figure 3A, Table S2f),
with indirect effects varying from 0.80 (95% CI 0.05, 2.47) in HE&PA to 0.97 (95% CI 0.07, 2.73) in
the HE group. At 35–37 weeks, satisfaction with social support for healthy eating at 24–28 weeks
mediated intervention effects in the HE group (indirect effect −0.61 (95% CI −1.93, −0.03) for portion
size (Figure 3B, Table S2f). Furthermore, outcome expectancy of a risk reduction for their baby and
task self-efficacy at 35–37 weeks mediated intervention effects on portion size at 35–37 weeks, both in
the HE&PA and HE groups (for outcome expectancy HE&PA: 0.96 (95% CI 0.06; 2.73), HE: 0.64 (95%
CI 0.02, 2.10) and for task self-efficacy HE&PA: −1.03 (95% CI −2.72, −0.12), HE: −0.85 (95% CI −2.24,
−0.11)).
None of the psychological variables at 24–28 or 35–37 weeks mediated intervention effects on
vegetable consumption (Table S2d) or carbohydrate intake (Table S2e) at 24–28 or at 35–37 weeks.
4. Discussion
We found that all three intervention groups in the DALI Lifestyle Study were associated with
increased outcome expectancy for the reduction of GDM risk and the risk to the baby, and with
increased task self-efficacy compared to the usual care group. Furthermore, although the interventions
were not specifically aimed at this, women were more satisfied with the social support they received
for being physically active in the combined HE&PA group and for healthy eating in the HE group.
The improvements in task self-efficacy were related to increased physical activity, reduced sugared
drink consumption and portion size. Increased satisfaction with social support for healthy eating was
related to decreased portion size. Unexpectedly, higher outcome expectancy of a risk reduction for the
baby was related to increased sugared drink consumption and portion size.
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Our findings confirm the importance of self-efficacy for behaviour change. Self-efficacy is well
established as determinant of a healthy lifestyle and lifestyle changes. Recently, the importance
of self-efficacy as predictor of physical activity was shown in women with a history of GDM [16].
We now demonstrate the importance of self-efficacy both for moderate-to-vigorous physical activity
and for sugared drink consumption for obese pregnant women at risk of GDM. However, a review of
mechanisms of change specifically within motivational interviewing interventions found no evidence
for a mediating effect of self-efficacy in relation to behaviour change [27]. The authors found this
surprising since “self-efficacy is an important construct in motivational interviewing” and suggested
this lack of evidence might have been due to poor measurement of self-efficacy in previous studies.
We made sure that we linked the questions on self-efficacy for reaching weight, physical activity and
dietary goals to the relevant behaviours. Furthermore, we measured it on a 10-point scale, and did not
have problems with ceiling effects in our population. This might explain why we found significant
mediation of self-efficacy of effects on moderate-to-vigorous physical activity and sugared drink
consumption after a motivational interviewing intervention. However, the statements for measuring
self-efficacy and, also, the other psychological variables, might have lacked specificity for the other
behaviours (sedentary behaviour, vegetable and carbohydrate intake) for which no mediation by
self-efficacy was found. For future interventions, the behaviour change techniques most suited for
improving task self-efficacy should be identified and integrated in the intervention, as suggested by
Ainscough et al., who developed a decision tree to support the development of antenatal lifestyle
interventions [28].
Although the interventions increased the outcome expectancy that managing weight and
obtaining physical activity and nutrition goals would lead to a reduction in the risk for GDM, this was
not found to mediate intervention effects on lifestyle outcomes at 24–28 weeks, and only the effect on
moderate-to-vigorous physical activity at 35–37 weeks. This is partly in line with previous findings
in women with a history of GDM [16] and patients with diabetes [29], in whom outcome expectancy
was not associated with the intention to be physically active. More research is warranted to elucidate
the role of outcome expectancies in prevention trials. More so, as we did find mediation by outcome
expectancy of a reduction of risk to the baby for intervention effects on sugared drink consumption
and portion size, but in an unexpected direction: increased outcome expectancy led to less beneficial
behaviour in both cases. We have no plausible explanation for this finding. Future qualitative research
may help to understand the link between outcome expectancies with regard to the baby’s health and
changes in eating behaviour.
In the DALI Lifestyle Study, risk perception of developing GDM was not changed by the
interventions. Overall, risk perception decreased somewhat over time, possibly after the majority of
women tested negatively for GDM at baseline and 24–28 weeks of gestation. In line with previous
studies, risk perception was not a predictor of behaviour change [16,30,31], which questions the
usefulness of this construct in the context of preventing GDM. According to the HAPA model,
risk perception is important for intention formation (i.e., in the motivation phase), and not in the
volition phase. Therefore, it is likely that in the context of our DALI Lifestyle Study, in which women
participated voluntarily and were likely motivated for behaviour change to start with, risk perception
does not play a role in behaviour change.
Although no significant intervention effects were found on sugared drink consumption at
24–28 weeks, mediation by both outcome expectancy of risk reduction for the baby and task self-efficacy
was found. The mediating effects were in opposite directions (i.e., high task self-efficacy reduced
sugared drink consumption and a high outcome expectancy increased consumption), which might
have cancelled each other out and, therefore, limited intervention effects at this point in time. Also,
for portion size mediation, satisfaction with social support without significant intervention effects in
the HE&PA and PA groups was found. Apparently, there are some unmeasured mediators that work
in opposite directions.
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We only found limited intervention effects on satisfaction with social support for either physical
activity or healthy eating, which might explain why no mediation by this factor was found. In the
DALI interventions, social support was only discussed when women indicated to perceive too little
support as a barrier for behaviour change. However, our findings could suggest that more attention
should be paid to this aspect in the intervention, in order to achieve improvements, even when women
do not raise the issue themselves.
Strengths and Limitations
The study was grounded in behaviour change theory with key psychological constructs measured
over time. While the statements we used to question participants were almost similar to the ones
used in previous HAPA research, we did not test their psychometrics. However internal validity
could be inferred from the fact that self-efficacy for PA increased in both the HE&PA and PA group,
but not the HE group and, vice versa, self-efficacy for healthy eating increased in the HE&PA and
HE groups, but not the PA group. Another limitation of our study is that lifestyle outcomes were
self-reported. However, we used lifestyle outcomes that were closely related to the intervention
goals, and differentiated between psychological factors related to physical activity or to healthy eating.
For practical reasons, we unfortunately did not include any items for psychological factors specifically
related to sedentary behaviour, or to the specific healthy eating goals. This might explain why no
mediation was found for sedentary behaviour, or for vegetable and carbohydrate intake.
5. Conclusions
In conclusion, our motivational interviewing intervention was successful in increasing outcome
expectancy and task self-efficacy, both of which were related to improvements in some dietary and
physical activity behaviours. Our findings corroborate the importance of self-efficacy in the process
of improving lifestyle to improve clinical outcomes. The role of outcome expectancy for behaviour
change needs further study.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/2/311/s1,
Table S1: List of statements for assessing outcome expectancy, task self-efficacy and perceived social support.
Table S2a–f: Lifestyle outcomes at 24–28 weeks and 35–37 weeks, mediators at 24–28 weeks, Table S3: Total (c-path)
and direct (c’-path) intervention effects on lifestyle behaviours.
Author Contributions: All of the authors contributed to the conception and/or design of the trial, read and
corrected draft versions of the manuscript, and approved the final manuscript. M.N.M.v.P. wrote the first draft of
the paper and undertook statistical analyses. M.N.M.v.P. is Guarantor.
Funding: The project described has received funding from the European Community’s 7th Framework Programme
(FP7/2007–2013) under grant agreement no. 242187. In the Netherlands, additional funding was provided by
the Netherlands Organization for Health Research and Development (ZonMw) (grant no. 200310013). In Poland,
additional funding was obtained from Polish Ministry of Science (grant no. 2203/7. PR/2011/2). In Denmark,
additional funding was provided by the Odense University Free Research Fund. In the United Kingdom, the DALI
team acknowledge the support received from the NIHR Clinical Research Network: Eastern, especially the local
diabetes clinical and research teams based in Cambridge. In Spain, additional funding was provided by CAIBER
1527-B-226. The funders had no role in any aspect of the study beyond funding.
Acknowledgments: We thank the participants, coaches, research midwives/nurses, and health professionals
collaborating in the recruitment. We gratefully acknowledge the contribution of Professor F André van Assche
(KU Leuven, Department of Development and Regeneration: Pregnancy, Fetus and Neonate, Gynaecology
and Obstetrics, University Hospitals Leuven, Belgium) to the conception and design of the DALI study. Sadly,
Professor van Assche passed away before the submission of this paper.
Conflicts of Interest: The authors declare no conflicts of interest. All of the authors have completed the ICMJE
uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare no support from any organisation
for the submitted work beyond that below; no financial relationships with any organisations that might have an
interest in the submitted work in the previous three years; no other relationships or activities that could appear to
have influenced the submitted work.
Nutrients 2019, 11, 311 16 of 17
References
1. Devlieger, R.; Benhalima, K.; Damm, P.; van Assche, A.; Mathieu, C.; Mahmood, T.; Dunne, F.; Bogaerts, A.
Maternal obesity in Europe: Where do we stand and how to move forward?: A scientific paper commissioned
by the European Board and College of Obstetrics and Gynaecology (EBCOG). Eur. J. Obstet. Gynecol. Reprod.
Biol. 2016, 201, 203–208. [CrossRef] [PubMed]
2. Heslehurst, N.; Ells, L.J.; Simpson, H.; Batterham, A.; Wilkinson, J.; Summerbell, C.D. Trends in maternal
obesity incidence rates, demographic predictors, and health inequalities in 36 821 women over a 15-year
period. BJOG 2007, 114, 187–194. [CrossRef] [PubMed]
3. Brunner, S.; Stecher, L.; Ziebarth, S.; Nehring, I.; Rifas-Shiman, S.L.; Sommer, C.; Hauner, H.; von Kries, R.
Excessive gestational weight gain prior to glucose screening and the risk of gestational diabetes:
A meta-analysis. Diabetologia 2015, 58, 2229–2237. [CrossRef] [PubMed]
4. Chu, S.Y.; Callaghan, W.M.; Kim, S.Y.; Schmid, C.H.; Lau, J.; England, L.J.; Dietz, P.M. Maternal obesity and
risk of gestational diabetes mellitus. Diabetes Care 2007, 30, 2070–2076. [CrossRef] [PubMed]
5. Rogozin´ska, E.; Marlin, N.; Jackson, L.; Rayanagoudar, G.; Ruifrok, A.E.; Dodds, J.; Molyneaux, E.;
van Poppel, M.N.; Poston, L.; Vinter, C.A.; et al. Effects of antenatal diet and physical activity on maternal
and fetal outcomes: Individual patient data meta-analysis and health economic evaluation. Health Technol.
Assess. 2017, 21, 1–158. [CrossRef] [PubMed]
6. Bain, E.; Crane, M.; Tieu, J.; Han, S.; Crowther, C.A.; Middleton, P. Diet and exercise interventions for
preventing gestational diabetes mellitus. Cochrane Database Syst. Rev. 2015. [CrossRef] [PubMed]
7. Poston, L.; Bell, R.; Croker, H.; Flynn, A.C.; Godfrey, K.M.; Goff, L.; Hayes, L.; Khazaezadeh, N.; Nelson, S.M.;
Oteng-Ntim, E.; et al. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study):
A multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 2015, 3, 767–777. [CrossRef]
8. Dodd, J.M.; Cramp, C.; Sui, Z.; Yelland, L.N.; Deussen, A.R.; Grivell, R.M.; Moran, L.J.; Crowther, C.A.;
Turnbull, D.; McPhee, A.J.; et al. The effects of antenatal dietary and lifestyle advice for women who are
overweight or obese on maternal diet and physical activity: The LIMIT randomised trial. BMC 2014, 12, 161.
[CrossRef]
9. Jelsma, J.G.M.; van Poppel, M.N.M.; Galjaard, S.; Desoye, G.; Corcoy, R.; Devlieger, R.; van Assche, A.;
Timmerman, D.; Jans, G.; Harreiter, J.; et al. DALI: Vitamin D and lifestyle intervention for gestational
diabetes mellitus (GDM) prevention: An European multicentre, randomised trial—study protocol. BMC 2013,
13, 142. [CrossRef]
10. Miller, W.R.; Rollnick, S. Motivational Interviewing: Helping People Change, 3rd ed.; Guilford Press: New York,
NY, USA, 2013.
11. Simmons, D.; Devlieger, R.; van Assche, A.; Jans, G.; Galjaard, S.; Corcoy, R.; Adelantado, J.M.; Dunne, F.;
Desoye, G.; Harreiter, J.; et al. Effect of Physical Activity and/or Healthy Eating on GDM Risk: The DALI
Lifestyle Study. J. Clin. Endocrinol. Metab. 2017, 102, 903–913. [CrossRef]
12. Broekhuizen, K.; Simmons, D.; Devlieger, R.; van Assche, A.; Jans, G.; Galjaard, S.; Corcoy, R.;
Adelantado, J.M.; Dunne, F.; Desoye, G.; et al. Cost-effectiveness of healthy eating and/or physical activity
promotion in pregnant women at increased risk of gestational diabetes mellitus: Economic evaluation
alongside the DALI study, a European multicenter randomized controlled trial. Int. J. Behav. Med. 2018,
15, 23. [CrossRef] [PubMed]
13. Van Poppel, M.N.M.; Simmons, D.; Desoye, G. DALI Core Investigator Group. A Reduction in Sedentary
Behavior in Obese Women Reduces Neonatal Adiposity—The DALI Randomized Controlled Trial.
Diabetes 2018, 67, 1416. [CrossRef]
14. Schwarzer, R. Modeling health behavior change: How to predict and modify the adoption and maintenance
of health behaviors. J. Appl. Psychol. 2008, 57, 1–29. [CrossRef]
15. Lindström, J.; Neumann, A.; Sheppard, K.E.; Gilis-Januszewska, A.; Greaves, C.J.; Handke, U.; Pajunen, P.;
Puhl, S.; Pölönen, A.; Rissanen, A.; et al. Take action to prevent diabetes—the IMAGE toolkit for the
prevention of type 2 diabetes in Europe. Horm. Metab. Res. 2010, 42, S37–S55. [CrossRef] [PubMed]
16. Pinidiyapathirage, J.; Jayasuriya, R.; Cheung, N.W.; Schwarzer, R. Self-efficacy and planning strategies
can improve physical activity levels in women with a recent history of gestational diabetes mellitus.
Health Psychol. 2018, 33, 1062–1077. [CrossRef] [PubMed]
Nutrients 2019, 11, 311 17 of 17
17. Schwarzer, R.; Luszczynska, A. How to overcome health-compromising behaviors: The health action process
approach. Eur. J. Psychol. Assess. 2008, 13, 141–151. [CrossRef]
18. World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy;
WHO/NMH/MND/13.2.; World Health Organization: Geneva, Switzerland, 2013.
19. Rasmussen, K.M.; Yaktine, A.L. Weight Gain during Pregnancy: Reexamining the Guidelines; National Academies
Press: Washington, DC, USA, 2009.
20. Jensen, D.M.; Ovesen, P.; Beck-Nielsen, H.; Molsted-Pedersen, L.; Sorensen, B.; Vinter, C.; Damm, P.
Gestational weight gain and pregnancy outcomes in 481 obese glucose-tolerant women. Diabetes Care
2005, 28, 2118–2122. [CrossRef]
21. Asbjörnsdóttir, B.; Rasmussen, S.S.; Kelstrup, L.; Damm, P.; Mathiesen, E.R. Impact of restricted maternal
weight gain on fetal growth and perinatal morbidity in obese women with type 2 diabetes. Diabetes Care
2013, 36, 1102–1106. [CrossRef]
22. Chasan-Taber, L.; Schmidt, M.D.; Roberts, D.E.; Hosmer, D.; Markenson, G.; Freedson, P.S. Development and
Validation of a Pregnancy Physical Activity Questionnaire. Med. Sci. Sports Exerc. 2004, 36, 1750–1760.
[CrossRef]
23. Ainsworth, B.E.; Haskell, W.L.; Herrmann, S.D.; Meckes, N.; Bassett, D.R.; Tudor-Locke, C.; Greer, J.L.;
Vezina, J.; Whitt-Glover, M.C.; Leon, A.S. 2011 Compendium of Physical Activities: A second update of
codes and MET values. Med. Sci. Sports Exerc. 2011, 43, 1575–1581. [CrossRef]
24. Simmons, D.; Mandell, C.; Fleming, C.; Gatland, B.; Leakehe, L. Evaluation of a diabetes knowledge and
behaviour (DKB) questionnaire. Asia Pac. J. Clin. Nutr. 1994, 3, 193–200.
25. Hayes, A.F. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach;
Guilford Publications: New York, NY, USA, 2013.
26. Hayes, A.F.; Preacher, K.J. Statistical mediation analysis with a multicategorical independent variable. Br. J.
Math. Stat. Psychol. 2014, 67, 451–470. [CrossRef] [PubMed]
27. Copeland, L.; McNamara, R.; Kelson, M.; Simpson, S. Mechanisms of change within motivational
interviewing in relation to health behaviors outcomes: A systematic review. Patient Educ. Couns. 2015, 98,
401–411. [CrossRef] [PubMed]
28. Ainscough, K.M.; Lindsay, K.L.; O’Sullivan, E.J.; Gibney, E.R.; McAuliffe, F.M. Behaviour change in
overweight and obese pregnancy: A decision tree to support the development of antenatal lifestyle
interventions. Public Health Nutri. 2017, 20, 2642–2648. [CrossRef]
29. Allen, N.A. Social cognitive theory in diabetes exercise research: An integrative literature review.
Diabetes Educ. 2004, 30, 805–819. [CrossRef]
30. Perrier, M.-J.; Sweet, S.N.; Strachan, S.M.; Latimer-Cheung, A.E. I act, therefore I am: Athletic identity and
the health action process approach predict sport participation among individuals with acquired physical
disabilities. J. Sport Exerc. Psychol. 2012, 13, 713–720. [CrossRef]
31. Barg, C.J.; Latimer, A.E.; Pomery, E.A.; Rivers, S.E.; Rench, T.A.; Prapavessis, H.; Salovey, P.
Examining predictors of physical activity among inactive middle-aged women: An application of the
health action process approach. Health Psychol. 2012, 27, 829–845. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
